solutol hs 15 has been researched along with bufalin in 1 studies
| Studies (solutol hs 15) | Trials (solutol hs 15) | Recent Studies (post-2010) (solutol hs 15) | Studies (bufalin) | Trials (bufalin) | Recent Studies (post-2010) (bufalin) |
|---|---|---|---|---|---|
| 92 | 1 | 59 | 333 | 0 | 205 |
| Protein | Taxonomy | solutol hs 15 (IC50) | bufalin (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.45 | |
| Cytochrome P450 3A5 | Homo sapiens (human) | 2.76 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Angelova, A; Drechsler, M; Garamus, VM; Gong, Y; Li, N; Li, Y; Liu, J; Zou, A | 1 |
1 other study(ies) available for solutol hs 15 and bufalin
| Article | Year |
|---|---|
In situ phase transition of microemulsions for parenteral injection yielding lyotropic liquid crystalline carriers of the antitumor drug bufalin.
Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Area Under Curve; Biological Availability; Bufanolides; Caprylates; Decanoic Acids; Delayed-Action Preparations; Drug Compounding; Drug Liberation; Emulsions; Hexoses; Humans; Infusions, Parenteral; Kinetics; Liquid Crystals; Phase Transition; Polyethylene Glycols; Rats; Rats, Wistar; Stearic Acids; Triglycerides | 2019 |